TY  - JOUR
AU  - Barbarroja, Nuria
AU  - Ruiz-Ponce, Miriam
AU  - Cuesta-Lopez, Laura
AU  - Perez-Sanchez, Carlos
AU  - Lopez-Pedrera, Chary
AU  - Arias-de la Rosa, Ivan
AU  - Collantes-Estevez, Eduardo
PY  - 2022
DO  - 10.3389/fimmu.2022.997270
UR  - http://hdl.handle.net/10668/20593
T2  - Frontiers in immunology
AB  - Liver disease is one of the most important causes of morbidity and mortality worldwide whose prevalence is dramatically increasing. The first sign of hepatic damage is inflammation which could be accompanied by the accumulation of fat called...
LA  - en
PB  - Frontiers Research Foundation
KW  - Cardiovascular risk
KW  - Liver disease
KW  - Methotrexate
KW  - Non-alcoholic fatty liver disease
KW  - Psoriatic arthritis
KW  - Rheumatoid arthritis
KW  - Arthritis, psoriatic
KW  - Arthritis, rheumatoid
KW  - Biological products
KW  - Cardiovascular diseases
KW  - Heart disease risk factors
KW  - Humans
KW  - Inflammation
KW  - Leflunomide
KW  - Liver cirrhosis
KW  - Methotrexate
KW  - Non-alcoholic fatty liver disease
KW  - Risk factors
TI  - Nonalcoholic fatty liver disease in inflammatory arthritis: Relationship with cardiovascular risk.
TY  - research article
VL  - 13
ER  -